dyphylline has been researched along with Hepatitis E in 1 studies
Dyphylline: A THEOPHYLLINE derivative with broncho- and vasodilator properties. It is used in the treatment of asthma, cardiac dyspnea, and bronchitis.
dyphylline : An oxopurine that is theophylline bearing a 2,3-dihydroxypropyl group at the 7 position. It has broncho- and vasodilator properties, and is used in the treatment of asthma, cardiac dyspnea, and bronchitis. It is also an ingredient in preparations that have been promoted for coughs.
Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fontana, RJ | 1 |
Engle, RE | 1 |
Hayashi, PH | 1 |
Gu, J | 1 |
Kleiner, DE | 1 |
Nguyen, H | 1 |
Barnhart, H | 1 |
Hoofnagle, JH | 1 |
Farci, P | 1 |
1 other study available for dyphylline and Hepatitis E
Article | Year |
---|---|
Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study.
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Dyphylline; Hepatitis Antibodies; Hepat | 2022 |